Consent Decree More Than Likely for Hospira Plant, Analyst Says

Recent feedback from FDA quality control consultants suggests the manufacturing problems bedeviling Hospira, particularly at its Rocky Mount, N.C., plant, will take two to three years to resolve and force the FDA to issue a stock-shocking consent decree, a Wall Street analyst says.
Generic Line